Results of primary central nervous system lymphoma treated by radiation and chemotherapy: Retrospective analysis of twelve institutions in the Tokai district of Japan, 1995-1999

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 24, Issue 1, 2006, Pages 9-16

  Kawamura, Toshiki ^a   Ishiguchi, Tsuneo ^a   Shibamoto, Yuta ^b   Ogino, Hiroyuki ^b   Ishihara, Shunichi ^b   Yamada, Tetsuya ^b   Katada, Kazuhiro ^b   Suzuki, Kazunori ^b   Suzuki, Hiromasa ^b   Mimura, Mikio ^b  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b Chubu Radiation Oncology Group   (Japan)

Author keywords

Multi institutional treatment result; Primary central nervous system lymphoma; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LACTATE DEHYDROGENASE; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; PROCARBAZINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; KAPLAN MEIER METHOD; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LUMBAR PUNCTURE; MALE; MENINGEAL METASTASIS; MULTIVARIATE ANALYSIS; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RELAPSE; REMISSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JAPAN; LYMPHOMA; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 32844463010     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489983     Document Type: Article

References (26)

1. Woodman R, Shin K, Pineo G. Primary non-Hodgkin's lymphoma of the brain. A review. Medicine Baltimore, 64: 425-430, 1985.
2. Hayakawa T, Takakura K, Abe H, et al. Primary central nervous system lymphoma in Japan: a retrospective, cooperative study by CNS-Lymphoma Study Group in Japan. J Neurooncol, 19: 197-215, 1994.
3. Hayabuchi N, Shibamoto Y, Onizuka Y. Primary central nervous system lymphoma in Japan: a nationwide survey. Int J Radiat Oncol Biol Phys, 44: 265-272, 1999.
4. Shibamoto Y, Tsuchida E, Seki K, et al. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years. J Cancer Res Clin Oncol, 130: 351-356, 2004.
5. Mikata A. A new histological classification of malignant lymphomas (LSG classification) and its significance. Nippon Ketsueki Gakkai Zasshi, 44: 1401-1410, 1981.
6. DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol, 43: 249-257, 1999.
7. DeAngelis LM. Current management of primary central nervous system lymphoma. Oncology (Williston Park), 9: 63-71, 1995.
8. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys, 23: 9-17, 1992.
9. Bray JY, Lasset C, Carrie C, et al. Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring. Br J Cancer, 67: 1136-1141, 1993.
10. Laperriere NJ, Cerezo L, Milosevic MF, Wong CS, Patterson B, Panzarella T. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother Oncol, 43: 247-252, 1997.
11. Blay JY, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol, 16: 864-871, 1998.
12. Corry J, Smith JG, Wirth A, Quong G, Liew KH. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys, 41: 615-620, 1998.
13. Shibamoto Y, Hayabuchi N, Hiratsuka J, et al. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation. Cancer, 97: 128-133, 2003.
14. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg, 81: 188-195, 1994.
15. Neuwelt EA, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol, 9: 1580-1590, 1991.
16. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol, 16: 859-863, 1998.
17. O'Brien P, Roos D, Pratt G, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol, 18: 519-526, 2000.
18. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg, 65: 600-607, 1986.
19. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg, 68: 835-853, 1988.
20. Ishikawa H, Hasegawa M, Tamaki Y, et al. Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma. Jpn J Clin Oncol, 33: 443-449, 2003.
21. Reni M, Ferreri AJ, Garancini MP, Villa E. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol, 8: 227-234, 1997.
22. Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer, 65: 1907-1912, 1990.
23. Bessell EM, Graus F, Punt JA, et al. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol, 14: 945-954, 1996.
24. Brada M, Dearnaley D, Horwich A, Bloom HJ. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys, 18: 787-792, 1990.
25. O'Neill BP, O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys, 33: 663-673, 1995.
26. Schultz C, Scott C, Sherman W, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol, 14: 556-564, 1996.